Ignite Creation Date:
2024-05-05 @ 11:19 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01307592
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2011-03-01
Brief Title:
Gemcitabine Hydrochloride Rituximab Oxaliplatin and Lenalidomide in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma
Sponsor:
Auxilio Mutuo Cancer Center
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000695874
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Auxilio Mutuo Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None